Signati Medical Reports the IDE Trial Completion of Separo Vessel Sealing System for Vasectomy Procedures
Shots:
- Signati Medical has successfully concluded the Investigational Device Exemption (IDE) study assessing Separo Vessel Sealing System for vasectomy procedures
- Study achieved 1EPs among all 8 patients, confirming the preclinical data & showing device’s tolerability without any AEs. The data suggested Separo Vessel Sealing System's potential to revolutionize vasectomy with a safer, efficient & minimally invasive approach
- Based on these outcomes, Signati Medical will begin De Novo process with the US FDA to seek market clearance for the device
Ref: Signati Medical | Image: Signati Medical
Related News:- Mainz Biomed Partners with Quest Diagnostics to Commercialize its Colorectal Cancer Screening Test
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
